Status:
COMPLETED
Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women
Lead Sponsor:
Iran University of Medical Sciences
Conditions:
Postmenopausal
Hyperlipidemia
Eligibility:
FEMALE
51-57 years
Phase:
NA
Brief Summary
paraoxonase 1 is involved to prevent LDL and HDL oxidation,so increase of it's activity leads to lower risk of coronary heart disease.In postmenopausal women ,we have decrease of paraoxonase1 activity...
Detailed Description
In a double blind clinical randomised clinical trial with parallel design this study was done.52 postmenopausal women were randomly assigned to 50 g/d soy protein or placebo for 10 weeks.serum lipopro...
Eligibility Criteria
Inclusion
- Cessation of menes for more than 1 year, elevation for more than 1 year
- Elevation of FSH level
- Total cholesterol
- Triglyceride more than 200 mg/dl
Exclusion
- Chronic disease (heart disease, cancer, diabetes, hepatic, kidney and thyroid disease)
- Antihypertensive drugs
- Antibiotics
- Lipid lowering drugs
- Sex hormone treatment
- Hysterectomy
- Diet rich in soy protein
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00457262
Start Date
January 1 2006
End Date
August 1 2006
Last Update
April 6 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.